Similarly, inhibitors targeting DDR-related genes, such as DNA-dependent protein kinase, catalytic subunit, ATM, ataxia telangiectasia and Rad3-related protein, CHK1, and WEE1, exhibit promising anti-cancer effects (Wengner et al., 2020). The gene discussed is ATM; the disease is cancer.